| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |